News

Vyant Bio to Present at the H.C. Wainwright Global Investment Hybrid Conference

Cherry Hill, N.J., May 19, 2022 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio” or “Company”) (Nasdaq: VYNT), is an…

2 years ago

Amarin Announces Appointment of New Directors and Board Leadership Changes

Erin Enright and Alfonso “Chito” Zulueta Appointed to Board of Directors New Board Members Bring Skills and Experience Aligned with…

2 years ago

Shockwave IVL Maintains Superiority to Angioplasty in Calcified Peripheral Disease at Two Years

Randomized Disrupt PAD III Study Finds Superior Vessel Preparation Leads to Excellent Long-Term Outcomes and Preserved Future Treatment OptionsSANTA CLARA,…

2 years ago

Clearmind Medicine Announces Successful Pre-Clinical Results in MEAI Treatment for Alcohol Consumption

Pre-clinical trial demonstrated high safety profile in addition to a significant suppressive effect on alcohol consumption VANCOUVER, May 19, 2022 (GLOBE NEWSWIRE)…

2 years ago

Adverum Biotechnologies Presents Research Pipeline Data Supporting Utility of its Proprietary Platform and AAV.7m8 Capsid in Ocular Gene Therapy

REDWOOD CITY, Calif., May 19, 2022 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage gene therapy company targeting…

2 years ago

ADC partners with Alt Magic to launch the first WebXR Cannabis Store in Metaverse

ASHEVILLE, N.C., May 19, 2022 (GLOBE NEWSWIRE) -- ADC, a leading cannabis distribution company, announced a partnership with Alt Magic…

2 years ago

BioCorRx and 2B3D to Pilot First-of-its-Kind PTSD and Addiction Treatment Solutions for Veterans in Metaverse Setting

Collaboration to create a synergistic treatment offering, combining BioCorRx’s MAT treatment program and 2B3D virtual reality technology Plans toward expanding…

2 years ago

Cullinan Oncology to Present at H.C. Wainwright Global Investment Conference

CAMBRIDGE, Mass., May 19, 2022 (GLOBE NEWSWIRE) -- Cullinan Oncology, Inc. (Nasdaq: CGEM) (“Cullinan”) a biopharmaceutical company focused on developing…

2 years ago

Larimar Therapeutics Announces Upcoming Poster Presentations at the 4th Pan American Parkinson’s Disease and Movement Disorders Congress

BALA CYNWYD, Pa., May 19, 2022 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR), a clinical-stage biotechnology company focused…

2 years ago

Sterigenics Announces Increased Electron Beam Sterilization Capacity to Support Healthcare Industry Needs

OAK BROOK, Ill., May 19, 2022 (GLOBE NEWSWIRE) -- Sterigenics®, a business of Sotera Health, and a global leader in…

2 years ago